CPRX
NASDAQ · Biotechnology
Catalyst Pharmaceuticals Inc
$31.38
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+28.87%
1Y
+41.86%
YTD
+35.55%
Open$31.38
Previous Close$31.38
Day High$31.40
Day Low$31.36
52W High$32.56
52W Low$19.05
Volume—
Avg Volume1.82M
Market Cap3.84B
P/E Ratio17.36
EPS$1.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$23.76
Above
SMA 200
$22.30
Above
RSI (14)
48.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
12 analysts
Price Target
+59.8% upside
Current
$31.38
$31.38
Target
$50.13
$50.13
$36.48
$50.13 avg
$69.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 566.60M | 404.42M | 680.16M |
| Net Income | 206.18M | 132.45M | -27,885,830 |
| Profit Margin | 36.4% | 34.6% | -4.1% |
| EBITDA | 284.05M | 192.61M | -33,860,903 |
| Free Cash Flow | — | — | -33,852,425 |
| Rev Growth | +40.1% | +40.1% | +20.9% |
| Debt/Equity | — | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $230.01 | +6.25% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $344.72 | +2.11% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $124.87 | +0.90% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $466.79 | +3.36% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $612.50 | +0.42% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.41 | +2.99% | 64.3 | 37.13B |